Stock UniverseDerived research view · source repositories remain read-only

Haemonetics Corporation (HAE)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Devices
Score Band
Qualified
Selection Score
36.21
Global Rank
1047
Market Cap
2.94B
Latest Close
71.28
RS Composite
0.50% · G#1318

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
35.33%
3M
11.15%
6M
-12.98%
1Y
2.33%
3Y
-15.74%
5Y
26.25%
10Y
154.57%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 491.43K · 30-day average: 898.18K · Max drawdown over stored range: -68.62%

Research Snapshot

Relative Strength vs SPX

RS Composite0.50%
20D RS30.47%
60D RS8.61%
120D RS-22.59%
Global RS Rank1318 · 60.72% percentile
Qualified+ RS Rank472 · 62.48% percentile
Group ScopeQualified+
Primary RS Rank38 · 73.24% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank75 / 246
Primary Percentile69.92
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2025-12-272026-02-051.32B782.42M251.09M175.44M3.65484.95M43.29M441.66M48M59.35%19.05%13.31%36.79%33.50%363.37M919.99M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2025-12-27$3.6519.6x$27.402.6x$9.187.8x$10.087.1x

Shares Diluted: 48M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Revenue870.463993.1961168.661309.0551360.8241334.03
Revenue Growth (YoY)-11.939%14.1%17.667%12.013%3.955%-1.969%
Gross Profit428.446530.77622.873711.915778.546
Operating Income100.096105.171167.2206.837247.1
Free Cash Flow71.76575.75481.731143.626142.447260.441
Free Cash Flow Per Share1.3991.4751.5892.7942.8085.49987
EPS (Diluted) GAAP1.550.842.242.293.31
EPS Growth4.73%-45.806%166.667%2.232%44.541%-38.066%
EPS Non-GAAP
Gross Margin49.22%53.441%53.298%54.384%57.211%59.0382%
Operating Margin11.499%10.589%14.307%15.8%18.158%11.7489%
Profit Margin9.13%4.367%9.875%8.98%12.322%7.2943%
Free Cash Flow Margin8.244%7.627%6.994%10.972%10.468%19.5229%
Shares Outstanding (Diluted)51.29251.35351.4251.39750.7347.354
Shares Change (YoY)-1.009%0.119%0.13%-0.045%-1.298%-6.655%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q32026-02-05338.97M59.71%67.40M19.88%44.74M13.20%0.9546.99M363.37M919.99Mprocessed
2026 Q22025-11-06327.31M59.50%58.49M17.87%38.68M11.82%0.8147.66M296.43M920.39Mprocessed
2026 Q12025-08-07321.39M59.82%53.87M16.76%34.03M10.59%0.7048.35M292.90M920.83Mprocessed
2025 Q42025-05-21330.60M58.39%71.33M21.58%57.98M17.54%1.1749.48M306.76M921.23Mprocessed
2025 Q32025-02-06348.54M55.53%59.03M16.94%37.49M10.76%0.7450.64M320.85M1.22Bprocessed
2025 Q22024-11-07345.51M54.25%51.70M14.96%33.83M9.79%0.6651.24M299.28M1.22Bprocessed
2025 Q12024-08-08336.17M52.03%39.76M11.83%38.37M11.41%0.7451.56M344.43M1.22Bprocessed
2024 Q42024-05-20343.29M51.24%29.94M8.72%20.37M5.93%0.4051.41M178.80M797.56Mprocessed
2024 Q32024-02-08336.25M52.90%45.98M13.67%31.24M9.29%0.6151.45M193.98M856.85Mprocessed
2024 Q22023-11-02318.18M53.59%35.30M11.10%24.91M7.83%0.4851.40M351.00M748.66Mprocessed
2024 Q12023-08-08311.33M53.73%53.66M17.24%41.04M13.18%0.8051.34M285.72M751.38Mprocessed
2023 Q42023-05-22n/an/a35.26Mn/a29.38Mn/a0.5751.22M284.47M754.10Mprocessed
2023 Q32023-02-07305.30M51.98%43.28M14.18%32.94M10.79%0.6451.22M224.00M756.83Mprocessed
2023 Q22022-11-08297.49M53.07%46.73M15.71%33.20M11.16%0.6451.56M241.20M759.55Mprocessed
2023 Q12022-08-10261.46M54.41%30.77M11.77%19.88M7.60%0.3851.68M214.95M763.14Mprocessed
2022 Q42022-05-25n/an/a19.20Mn/a9.74Mn/a0.1951.34M259.50M559.44Mprocessed
2022 Q32022-02-08259.77M53.34%35.65M13.72%23.23M8.94%0.4551.34M236.88M633.12Mprocessed
2022 Q22021-11-09239.90M51.08%24.51M10.22%14.86M6.19%0.2951.46M192.42M698.04Mprocessed
2022 Q12021-08-11228.53M47.30%1.39M0.61%-4.45M-1.95%-0.0950.94M173.46M767.35Mprocessed
2021 Q42021-05-26n/an/a-21.18Mn/a-11.04Mn/a-0.2151.47M192.31M690.59Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.